227 related articles for article (PubMed ID: 35178352)
1. Hinokiflavone Inhibits Growth of Esophageal Squamous Cancer By Inducing Apoptosis
Guo J; Zhang S; Wang J; Zhang P; Lu T; Zhang L
Front Oncol; 2022; 12():833719. PubMed ID: 35178352
[TBL] [Abstract][Full Text] [Related]
2. β-elemene Suppresses Migration of Esophageal Squamous Cell Carcinoma by Modulating Expression of MMP9 through the PI3K/Akt/NF-κB Pathway.
Liang Y; Li S
Comb Chem High Throughput Screen; 2023; 26(13):2304-2320. PubMed ID: 36872359
[TBL] [Abstract][Full Text] [Related]
3. Protein Arginine Methyltransferase 5 Promotes Esophageal Squamous Cell Carcinoma Proliferation and Metastasis via LKB1/AMPK/mTOR Signaling Pathway.
Chen YR; Li HN; Zhang LJ; Zhang C; He JG
Front Bioeng Biotechnol; 2021; 9():645375. PubMed ID: 34124017
[No Abstract] [Full Text] [Related]
4.
Zheng Y; Luo M; Lü M; Zhou T; Liu F; Guo X; Zhang J; Kang M
Onco Targets Ther; 2020; 13():11193-11209. PubMed ID: 33173311
[TBL] [Abstract][Full Text] [Related]
5. Hinokiflavone induces apoptosis via activating mitochondrial ROS/JNK/caspase pathway and inhibiting NF-κB activity in hepatocellular carcinoma.
Mu W; Cheng X; Zhang X; Liu Y; Lv Q; Liu G; Zhang J; Li X
J Cell Mol Med; 2020 Jul; 24(14):8151-8165. PubMed ID: 32519392
[TBL] [Abstract][Full Text] [Related]
6. mTOR inhibitor PP242 increases antitumor activity of sulforaphane by blocking Akt/mTOR pathway in esophageal squamous cell carcinoma.
Lu Z; Zhang Y; Xu Y; Wei H; Zhao W; Wang P; Li Y; Hou G
Mol Biol Rep; 2022 Jan; 49(1):451-461. PubMed ID: 34731371
[TBL] [Abstract][Full Text] [Related]
7. HERG1 promotes esophageal squamous cell carcinoma growth and metastasis through TXNDC5 by activating the PI3K/AKT pathway.
Wang H; Yang X; Guo Y; Shui L; Li S; Bai Y; Liu Y; Zeng M; Xia J
J Exp Clin Cancer Res; 2019 Jul; 38(1):324. PubMed ID: 31331361
[TBL] [Abstract][Full Text] [Related]
8. Omipalisib Inhibits Esophageal Squamous Cell Carcinoma Growth Through Inactivation of Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) and ERK Signaling.
Zhu DS; Dong JY; Xu YY; Zhang XT; Fu SB; Liu W
Med Sci Monit; 2020 Aug; 26():e927106. PubMed ID: 32804918
[TBL] [Abstract][Full Text] [Related]
9. Sporoderm-Removed
Liu G; Zeng T
Integr Cancer Ther; 2021; 20():15347354211062157. PubMed ID: 34841952
[TBL] [Abstract][Full Text] [Related]
10. XPD inhibits cell growth and invasion and enhances chemosensitivity in esophageal squamous cell carcinoma by regulating the PI3K/AKT signaling pathway.
Jian J; Li S; Liu LZ; Zhen L; Yao L; Gan LH; Huang YQ; Fang N
Int J Mol Med; 2020 Jul; 46(1):201-210. PubMed ID: 32377720
[TBL] [Abstract][Full Text] [Related]
11. Homeobox D10, a tumor suppressor, inhibits the proliferation and migration of esophageal squamous cell carcinoma.
Zhang J; Liu S; Zhang D; Ma Z; Sun L
J Cell Biochem; 2019 Aug; 120(8):13717-13725. PubMed ID: 30938888
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of DEAD-box 51 inhibits tumor growth of esophageal squamous cell carcinoma
Hu DX; Sun QF; Xu L; Lu HD; Zhang F; Li ZM; Zhang MY
World J Gastroenterol; 2022 Jan; 28(4):464-478. PubMed ID: 35125830
[TBL] [Abstract][Full Text] [Related]
13. Hesperetin Inhibits Bladder Cancer Cell Proliferation and Promotes Apoptosis and Cycle Arrest by PI3K/AKT/FoxO3a and ER Stress-mitochondria Pathways.
Su Y; Chen L; Yang J
Curr Med Chem; 2024 Feb; ():. PubMed ID: 38357946
[TBL] [Abstract][Full Text] [Related]
14. Epb41l3 suppresses esophageal squamous cell carcinoma invasion and inhibits MMP2 and MMP9 expression.
Zeng R; Huang JP; Li XF; Xiong WB; Wu G; Jiang ZJ; Song SJ; Li JQ; Zheng YF; Zhang JR
Cell Biochem Funct; 2016 Apr; 34(3):133-41. PubMed ID: 26916087
[TBL] [Abstract][Full Text] [Related]
15. Hematoporphyrin derivative photodynamic therapy induces apoptosis and suppresses the migration of human esophageal squamous cell carcinoma cells by regulating the PI3K/AKT/mTOR signaling pathway.
Wei X; Ni J; Yuan L; Li X
Oncol Lett; 2024 Jan; 27(1):17. PubMed ID: 38034489
[TBL] [Abstract][Full Text] [Related]
16. Xihuang pills induce apoptosis in hepatocellular carcinoma by suppressing phosphoinositide 3-kinase/protein kinase-B/mechanistic target of rapamycin pathway.
Teng YJ; Deng Z; Ouyang ZG; Zhou Q; Mei S; Fan XX; Wu YR; Long HP; Fang LY; Yin DL; Zhang BY; Guo YM; Zhu WH; Huang Z; Zheng P; Ning DM; Tian XF
World J Gastrointest Oncol; 2022 Apr; 14(4):872-886. PubMed ID: 35582102
[TBL] [Abstract][Full Text] [Related]
17. ET-1 promotes the growth and metastasis of esophageal squamous cell carcinoma via activating PI3K/Akt pathway.
Yin H; Wang L; Li F; Wang D; Zhang Z; Yu B; Liu Y
Transl Cancer Res; 2020 May; 9(5):3282-3292. PubMed ID: 35117695
[TBL] [Abstract][Full Text] [Related]
18. LncRNA HCP5 promotes malignant cell behaviors in esophageal squamous cell carcinoma via the PI3K/AKT/mTOR signaling.
Xu J; Ma J; Guan B; Li J; Wang Y; Hu S
Cell Cycle; 2021 Jul; 20(14):1374-1388. PubMed ID: 34190001
[TBL] [Abstract][Full Text] [Related]
19. Capilliposide C Sensitizes Esophageal Squamous Carcinoma Cells to Oxaliplatin by Inducing Apoptosis Through the PI3K/Akt/mTOR Pathway.
Shen Z; Xu L; Li J; Zhang N
Med Sci Monit; 2017 May; 23():2096-2103. PubMed ID: 28463955
[TBL] [Abstract][Full Text] [Related]
20. circ_NRIP1 is oncogenic in malignant development of esophageal squamous cell carcinoma (ESCC) via miR-595/SEMA4D axis and PI3K/AKT pathway.
Zhou S; Guo Z; Zhou C; Zhang Y; Wang S
Cancer Cell Int; 2021 May; 21(1):250. PubMed ID: 33957921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
